Page last updated: 2024-12-07

dibromosulphthalein

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dibromosulphthalein (BSP) is a dye used in medical imaging and research. It is a derivative of phenolphthalein, a common indicator. BSP is primarily used to assess liver function by measuring its clearance from the blood. The liver plays a crucial role in the excretion of bile pigments and other waste products, and BSP is efficiently taken up by the liver and excreted in the bile. The rate of removal of BSP from the blood is directly proportional to the liver's functional capacity. It is injected intravenously, and the amount of BSP remaining in the blood after a certain time is measured. This information is then used to estimate the liver's functional capacity. BSP is also used in research studies on the liver, as well as to study the effects of various drugs on the liver.'
```

dibromosulphthalein: RN refers to 3H-labeled parent compound [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID86995
CHEMBL ID2074600
MeSH IDM0059531

Synonyms (14)

Synonym
dibromsulphalein
[4-[4,7-dibromo-3-oxo-1-(4-sulfooxyphenyl)-2-benzofuran-1-yl]phenyl] hydrogen sulfate
dibromosulfothalein
3,6-dibromosulfophthalein
benzenesulfonic acid, 3,3'-(4,7-dibromo-3-oxo-1(3h)-isobenzofuranylidene)bis(6-hydroxy-
dibromosulfthalein
phenol-3,6-dibromophthalein disulfonate
17199-35-8
dibromosulphthalein
dibromsulphthalein
dibromosulfophthalein
CHEMBL2074600 ,
bdbm50420231
DTXSID10169197

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Administration of the non-metabolizable organic anion indocyanine green (ICG) prior to a toxic dose of acetaminophen (4-acetamidophenol; APAP) reduces liver injury 24h after dosing."( Cholestasis induced by model organic anions protects from acetaminophen hepatotoxicity in male CD-1 mice.
Hennig, GE; Manautou, JE; Silva, VM, 2006
)
0.33

Pharmacokinetics

ExcerptReferenceRelevance
"This study contains a pharmacokinetic analysis on the efflux of organic anions from the liver into the bloodstream (sinusoidal efflux) with specific reference to the influence of albumin."( Pharmacokinetic modeling of the sinusoidal efflux of anionic ligands from the isolated perfused rat liver: the influence of albumin.
Groothuis, GM; Meijer, DK; Nijssen, HM; Proost, JH; Strating, CB, 1993
)
0.29

Dosage Studied

ExcerptRelevanceReference
" In these studies, overnight fasted male CD-1 mice were dosed (i."( Cholestasis induced by model organic anions protects from acetaminophen hepatotoxicity in male CD-1 mice.
Hennig, GE; Manautou, JE; Silva, VM, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier family 22 member 6Rattus norvegicus (Norway rat)Ki2.74001.60005.744010.0000AID679489
Solute carrier family 22 member 8Rattus norvegicus (Norway rat)Ki3.09003.09005.54009.1000AID679175
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID679024TP_TRANSPORTER: inhibition of GR biliary excretion (70.8->23.5 % of dose, DBSP: 3 uM/min/kg iv infusion, GR: 10 mg/kg iv) in SD rat1996Pharmaceutical research, Dec, Volume: 13, Issue:12
Biliary excretion of glycyrrhizin in rats: kinetic basis for multiplicity in bile canalicular transport of organic anions.
AID679813TP_TRANSPORTER: biliary excretion in SD rat1993The Journal of pharmacology and experimental therapeutics, Jun, Volume: 265, Issue:3
Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
AID679175TP_TRANSPORTER: inhibition of Pravastatin uptake in Oat3-expressing LLC-PK1 cells2002The Journal of pharmacology and experimental therapeutics, Mar, Volume: 300, Issue:3
Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions.
AID682093TP_TRANSPORTER: inhibition of Temocaprilat uptake (Temocaprilat: 0.1 uM, DBSB: 100 uM) in Oatp1-expressing COS-7 cells1998The Journal of pharmacology and experimental therapeutics, Oct, Volume: 287, Issue:1
Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide.
AID679814TP_TRANSPORTER: biliary excretion in EHBR rat1993The Journal of pharmacology and experimental therapeutics, Jun, Volume: 265, Issue:3
Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
AID679025TP_TRANSPORTER: inhibition of GR biliary excretion (70.8->23.5 % of dose, DBSP: 3 uM/min/kg iv infusion, GR: 10 mg/kg iv) in EHBR rat1996Pharmaceutical research, Dec, Volume: 13, Issue:12
Biliary excretion of glycyrrhizin in rats: kinetic basis for multiplicity in bile canalicular transport of organic anions.
AID679489TP_TRANSPORTER: inhibition of PAH uptake in Oat1-expressing LLC-PK1 cells2002The Journal of pharmacology and experimental therapeutics, Mar, Volume: 300, Issue:3
Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (58)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (37.93)18.7374
1990's25 (43.10)18.2507
2000's10 (17.24)29.6817
2010's1 (1.72)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.09 (24.57)
Research Supply Index4.17 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other64 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]